Source:http://linkedlifedata.com/resource/pubmed/id/21236472
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-22
|
pubmed:abstractText |
An alternative pathway for fibrinolysis that comprises leukocyte elastase and its interaction with the plasminogen activator-plasmin system has been suggested. Plasma levels of cross-linked fibrin degradation product by leukocyte elastase (e-XDP) were significantly increased in patients with sepsis induced disseminated intravascular coagulation (DIC) compared with healthy subjects (18.6±19.9 vs 0.58±0.47U/mL, p<0.001). Twenty seven unique spots were identified from e-XDP dominant patients by immune-purification and two-dimensional difference gel electrophoresis, and they contained fibrinogen B?-chain derived fragments B? Asp-164, Ser-200, Gln-301, Ala-354, Ile-484 and ?-chain derivatives ? Val-274 at their amino-termini by acquired and processed tandem mass spectrometer. The Sequential Organ Failure Assessment Scores in patients with e-XDPs levels 3-10U/mL were significantly lower than those with e-XDPs levels -3U/mL, 10-30U/mL, and 30- U/mL. The adjusted odds for 28-day mortality rate in patients with e-XDP levels less than 3U/mL (hazard ratio, 4.432; 95% CI, 1.557-12.615 [p=0.005]) were significantly higher than those in patients with e-XDP levels of 3-10U/mL. These data suggest that leukocyte elastase might contribute to the degradation of cross-linked fibrin in sepsis-induced DIC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1879-2472
|
pubmed:author |
pubmed-author:DokaiMomokoM,
pubmed-author:IshiwataAkiraA,
pubmed-author:KashiwakuraYujiY,
pubmed-author:MadoiwaSeijiS,
pubmed-author:MimuroJunJ,
pubmed-author:NagahamaYutakaY,
pubmed-author:OhmoriTsukasaT,
pubmed-author:SakataAsukaA,
pubmed-author:SakataYoichiY,
pubmed-author:TanakaHideyukiH,
pubmed-author:YasumotoAtsushiA
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
349-55
|
pubmed:meshHeading |
pubmed-meshheading:21236472-Aged,
pubmed-meshheading:21236472-Disseminated Intravascular Coagulation,
pubmed-meshheading:21236472-Female,
pubmed-meshheading:21236472-Fibrin,
pubmed-meshheading:21236472-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:21236472-Fibrinolysin,
pubmed-meshheading:21236472-Fibrinolysis,
pubmed-meshheading:21236472-Humans,
pubmed-meshheading:21236472-Leukocyte Elastase,
pubmed-meshheading:21236472-Male,
pubmed-meshheading:21236472-Middle Aged,
pubmed-meshheading:21236472-Prognosis,
pubmed-meshheading:21236472-Sepsis
|
pubmed:year |
2011
|
pubmed:articleTitle |
Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation.
|
pubmed:affiliation |
Research Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan. madochan@jichi.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|